Further, dermatologists can also monitor and screen for other potential autoimmune conditions associated with vitiligo, as ...

The financing is being led by Vivo Capital and includes participation by new and existing investors including Forge Life ...

University of Alberta-led researchers, including the developers and promoters of the Fracture Risk Assessment Tool (FRAX), ...

VANCOUVER, British Columbia and BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other low ...

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators ...

I was diagnosed with rheumatoid arthritis which I treat by suppressing by immune system. Working from home is key for me to ...

Exagen Inc., a leading provider of autoimmune testing, today announced the validation and regulatory submission for approval of new Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis (RA) ...

Use of adalimumab, one of the most popular biologics on the market today, has risen steadily since its initial approval for ...